Innovative Endocrinology of Cancer

Atthebeginningofthe21thcentury,hormone associated tumorsmadeupnotless 1 than30 40%ofallhumancancers. Thus,theimportanceoftheproblem both me- calandsocial was thefirstreasonforthecreationofthisvolume. Accordingly, the firstgoalofthebookwastoreviewdifferent aspectsoftheextensivefieldofresearch intheareacoveredbythenotion'hormonesandcancer'. First,howeverdoesnotnecessarily meanmain.Mostofus knowthatscienceis aboutaskingquestions and finding credibleways to answerthem and that it works bestina culturethatwelcomes challenges toprevailing dogmas.'Thus,theprincipal aimof thisvolumeis to describethesenew and attractive ideasandmethodswhich haveanimatedoncoendocrinolgyin recentyears.Tofulfill thistask,theco editors of thebookwereguidedbya desireto describe therichinnovation inthisfield. Asaresult,thevolumeisdevotedtothenew developments insuchtopicsas mechanisms ofhormonal carcinogenesis (contributions ofJ. Chenetal;J.RussoandI. Russo; L.Berstein), epidemiology andriskfactors (contributions ofS.Ukraintsevaet al;A.Hjartakeretal;A.H.EliassenandS.Hankinson), hormoneproductionbytumor tissue(contributionofS.BulunandE.Simpson) andhormonal sensitivityofthelatter (contribution of C. Langeet al),genesis,dichotomy and endocrinology of cancerin females (contribution of C. Griindker et al), pharmacogenomics and proteomics in oncoendocrinology (contributions ofD. Tysonand D. Ornstein; R. Weinshilboum), biological coreofhormonalandantihormonal therapyofcancer(contributions ofR. Santenetal;A.Buttetal;S.SenguptaandV. C.Jordan)anditsprevention (T. Powles' contribution). Asoncewassaidbyprominentwriter:'Novelistsareeither"large audience" or"small audience'".' Wearehopingthatreadership ofthebook(whichtestifies that endocrinologyofcancerhasgonealongandfruitful way)willincreasegradually and receivefurtherstimulus neededfor subsequent achievements inthisinteresting area. Lev M Berstein, MD, PhD, DMS RichardJ. Santen, MD 1. Parkin DM, Fernandez LM. Use of statistics to assess the global burden of